Disc Medicine, Inc.

IRONNASDAQHealthcareBiotechnology

$56.84- (-)1Y −37.01%

As of Oct 16, 2026 close

Market cap: $2.19B
P/E (TTM): -
Forward P/E: -
Dividend yield: -
52-week range: $40.00$99.50
Volume (live): -
Avg. volume (3M): 611.81K

Disc Medicine, Inc. (IRON) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Disc Medicine, Inc. stock.

Analyst Consensus Rating

Investment consensus from 12 professional research analysts

Consensus Rating

Buy

Based on 12 unique analysts

(14 total ratings in last 90 days)

High Confidence∞:1 Buy/Sell

Average Price Target

$102.22

+79.84% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest IRON Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Sep 22, 2026	Douglas Tsao	HC Wainwright	Reiterates	Buy	$120.00
Sep 21, 2026	Danielle Brill	Truist	Maintains	Buy	-
Sep 16, 2026	Derek Archila	Wells Fargo	Reiterates	Buy	$79.00 → $86.00 +7.00 (+8.9%)
Sep 11, 2026	Evan Seigerman	BMO Capital	Maintains	Buy	$100.00
Sep 10, 2026	Rami Katkhuda	LifeSci Capital	Maintains	Buy	$100.00
Sep 10, 2026	Thomas Smith	Leerink Partners	Reiterates	Buy	$100.00
Sep 10, 2026	Evan Seigerman	BMO Capital	Maintains	Buy	$100.00
Sep 1, 2026	Kristen Kluska	Cantor Fitzgerald	Maintains	Buy	$125.00
Aug 31, 2026	Kristen Kluska	Cantor Fitzgerald	Maintains	Buy	$125.00
Aug 17, 2026	Sean Laaman	Morgan Stanley	Reiterates	Buy	$85.00 → $90.00 +5.00 (+5.9%)
Aug 11, 2026	David Nierengarten	Wedbush	Maintains	Buy	$88.00
Jul 31, 2026	Stephen Willey	Stifel Nicolaus	Maintains	Buy	$111.00
Jul 30, 2026	Tara Bancroft	TD Cowen	Maintains	Buy	-
Jul 21, 2026	Bret Jensen	TheStreet.com	Initiates Coverage	Buy	-

Douglas Tsao

HC Wainwright

BuyReiterates

$120.00

Sep 22

Danielle Brill

Truist

BuyMaintains

Sep 21

Derek Archila

Wells Fargo

BuyReiterates

$79.00 → $86.00

Sep 16

Evan Seigerman

BMO Capital

BuyMaintains

$100.00

Sep 11

Rami Katkhuda

LifeSci Capital

BuyMaintains

$100.00

Sep 10

Thomas Smith

Leerink Partners

BuyReiterates

$100.00

Sep 10

Evan Seigerman

BMO Capital

BuyMaintains

$100.00

Sep 10

Kristen Kluska

Cantor Fitzgerald

BuyMaintains

$125.00

Sep 1

Kristen Kluska

Cantor Fitzgerald

BuyMaintains

$125.00

Aug 31

Sean Laaman

Morgan Stanley

BuyReiterates

$85.00 → $90.00

Aug 17

David Nierengarten

Wedbush

BuyMaintains

$88.00

Aug 11

Stephen Willey

Stifel Nicolaus

BuyMaintains

$111.00

Jul 31

Tara Bancroft

TD Cowen

BuyMaintains

Jul 30

Bret Jensen

TheStreet.com

BuyInitiates Coverage

Jul 21

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Sep 22, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for IRON?

The analyst consensus rating for IRON is Buy, based on the latest ratings from 12 analysts over the last 90 days.

What is the average price target for IRON?

The average 12-month price target for IRON is $102.22, representing an upside of 79.8% from the Oct 16, 2026 close of $56.84.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.